supplementary_material .docx (25.13 kB)

Analysis of GMP in Marketing Authorization for ATMPs: Comparison in the US, the EU, Japan, and South Korea. Supplementary material

dataset

posted on 02.03.2022, 08:57 by Hocheol Shin, Eunyoung Kim

Supplementary Table S1. List of authorized cell therapy

Supplementary Table S2. List of authorized gene therapy

Funding

NRF-2021R1F1A1062044

2021R1A6A1A03044296

History

Usage metrics

Read the peer-reviewed publication

Analysis of GMP in Marketing Authorization for ATMPs: Comparison in the US, the EU, Japan, and South Korea

Regenerative Medicine

Categories

Other health sciences not elsewhere classified

Keywords

GMP Gap analysis regulation regulatory system Marketing authorization Good manufacturing practice ATMPs Advanced therapy medicinal products Medical and Health Sciences not elsewhere classified

Licence

CC BY-NC-ND 4.0

Exports